Gene Therapy for Severe Beta Thalassemia Earns Conditional Marketing Approval in the EU
ColiN00B / Pixabay

Gene Therapy for Severe Beta Thalassemia Earns Conditional Marketing Approval in the EU

According to a story from BioPortfolio, the gene therapy company bluebird bio, Inc. recently announced that its gene therapy ZYNTEGLO™ has earned conditional marketing authorization in the European Union from…

Continue Reading Gene Therapy for Severe Beta Thalassemia Earns Conditional Marketing Approval in the EU
Clinical Trial Results Look Good for Possible Treatment for Transfusion Dependent Beta Thalassemia
sabinurce / Pixabay

Clinical Trial Results Look Good for Possible Treatment for Transfusion Dependent Beta Thalassemia

According to a story from Market Screener, the biopharmaceutical company Orchard Therapeutics recently announced that the results of a recent clinical trial testing the company' investigational product OTL-300 were encouraging.…

Continue Reading Clinical Trial Results Look Good for Possible Treatment for Transfusion Dependent Beta Thalassemia
Experimental Treatment for Anemia Associated With Beta Thalassemia Gets Fast Track Designation
allinonemovie / Pixabay

Experimental Treatment for Anemia Associated With Beta Thalassemia Gets Fast Track Designation

According to a story from PR Newswire, the drug developer Protagonist Therapeutics recently announced that its investigational therapy PTG-300 has earned Fast Track designation from the US Food and Drug…

Continue Reading Experimental Treatment for Anemia Associated With Beta Thalassemia Gets Fast Track Designation
Gene Therapy Could Put an End to Blood Transfusions for Beta Thalessemia Patients
JuralMin / Pixabay

Gene Therapy Could Put an End to Blood Transfusions for Beta Thalessemia Patients

According to a story from empr.com, a recent study revealed that gene therapy could allow patients with beta thalessemia to stop having to get regular blood transfusions. The gene therapy…

Continue Reading Gene Therapy Could Put an End to Blood Transfusions for Beta Thalessemia Patients